Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the post-hoc analysis of the Phase 3 ENHANCE study of CymaBay's seladelpar for the treatment of primary biliary cholangitis (PBC)

Ticker(s): CBAY

Who's the expert?

Institution: Dignity Health - St. Joseph's Hospital and Medical Center

Chief of Hepatology and Medical Director of Liver Transplant at St. Joseph's Hospital & Medical Center in Phoenix, Arizona.
Currently manages ~2000 patients with liver disease, 15-20 patients with A1AT liver disease, 40 with PBC
Research interests involve nonalcoholic steatohepatitis, cirrhosis, primary biliary cholangitis, primary sclerosing cholangitis, and liver transplant.

Interview Goal

On this call we will be digging in to CymaBay's new findings from the phase 3 ENHANCE study regarding the correlation of Seladepar and the alleviation of pruritus, reduction of serum IL-31 levels, and the overall potential of Seladelpar to treat patients with PBC.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.